Crossover Health has secured $15 million in funding from Norwest Venture Partners (NVP) to help scale its primary care and integrated health services. NVP’s Ryan Harris, MD and Casper de Clercq are the lead investors and will join the company’s board of directors.

Crossover will use the funds to continue to enhance its proprietary patient facing technology, create robust population health analytics capabilities, and staff for significantly expanded growth and service offerings.

The company was founded in 2010 to address the rising costs and limited innovation that continue to challenge employers; currently, it manages the on-site health care of more than 40,000 employees of numerous technology and manufacturing companies.

Norwest Venture Partners (NVP) is a global, multi-stage VC and growth equity investment firm that has partnered with entrepreneurs to build great businesses for more than 50 years. The firm manages approximately $5 billion in capital and has funded more than 550 companies since inception.